Polypharmacy in the treatment of subjects with intellectual disability.
about
Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study.Assessing the Impact of Psychotropic Medication Changes on Challenging Behavior of Individuals with Intellectual Disabilities.Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
P2860
Polypharmacy in the treatment of subjects with intellectual disability.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Polypharmacy in the treatment of subjects with intellectual disability.
@en
type
label
Polypharmacy in the treatment of subjects with intellectual disability.
@en
prefLabel
Polypharmacy in the treatment of subjects with intellectual disability.
@en
P2093
P2860
P1476
Polypharmacy in the treatment of subjects with intellectual disability.
@en
P2093
Frank Häβler
Johannes Thome
P2860
P2888
P304
P356
10.1007/S00702-014-1219-X
P478
122 Suppl 1
P577
2014-05-25T00:00:00Z